Why should clinical trials be registered?

June 2005
CMAJ: Canadian Medical Association Journal;6/21/2005, Vol. 172 Issue 13, p1653
Academic Journal
Comments on the reasons why clinical trials should be registered. Benefits of trial registration; View of pharmaceutical companies on public disclosure.


Related Articles

  • Credible Lit. Baiter, Wendy; Scott, Marsha // Pharmaceutical Executive;Aug2006, Vol. 26 Issue 8, p138 

    The article focuses on several developments in report publications in the pharmaceutical industry in the U.S. Review article development is moving together with the most forward-thinking companies developing internal guidelines that leave content development to the author. Another development is...

  • Transparency and Registries. Hindin, Toby Jane // Applied Clinical Trials;Apr2005, Vol. 14 Issue 4, p12 

    Reports on a number of drug companies who are taking the lead in setting up trial registries in the U.S. Impact of the disclosure of serious adverse events on public confidence in the pharmaceutical industry; Recommendation on the need for transparency in clinical trials; Efforts of industry...

  • Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors. De Angelis, Catherine; Drazen, Jeffrey M.; Frizelle, Frank A.; Haug, Charlotte; Hoey, John; Horton, Richard; Kotzin, Sheldon; Lame, Christine; Marusic, Ana; Overbeke, A. John P. M.; Schroeder, Torben V.; Sox, Harold C.; Van Der Weyden, Martin B. // Journal of Rehabilitation Research & Development;Jul/Aug2005, Vol. 42 Issue 4, preceding p1 

    The article reports that in September 2004, the members of the International Committee of Medical Journal Editors published a joint editorial aimed at promoting registration of all clinical trials. This policy applies to trials that start recruiting on or after July 1, 2005. A complete registry...

  • Keeping faith with trial volunteers. Piccart, Martine; Goldhirsch, Aron; Wood, William; Pritchard, Kathleen; Baselga, José; Reaby, Linda; Kössler, Ingrid; Kyriakides, Stella; Norton, Larry; Coates, Alan // Nature;3/8/2007, Vol. 446 Issue 7132, p137 

    The article argues that there is a need to maintain academic independence in early breast cancer clinical trials to best serve patients' interests. Important for patient groups are transparency in study design, data collection and analysis, and full publication of results. The conflict of...

  • Drug industry protests over need to register trial results. Roehr, Bob // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;4/25/2009, Vol. 338 Issue 7701, p969 

    The article reports on concerns which were expressed my members of the pharmaceutical industry in the U.S. in April of 2009. The members were concerned about a new requirement of the world's leading drug trial registry which mandated that the outcomes of all clinical trials have to be posted on...

  • Strong CNS Product Pipelines Are Attracting High Numbers of Clinical Trials:.  // Biomedical Market Newsletter;9/26/2011, Vol. 21, p761 

    The article offers information on the report "Clinical Trial Recruitment in Central Nervous System Disorders -- Highest Number of Patients were Recruited for Clinical Trials in Schizophrenia." The report available on companiesandmarkets.com unveils that the quantity of clinical trials conducted...

  • Clinical Trials Research in Pediatrics: Strategies for Effective Collaboration Between Investigator Sites and the Pharmaceutical Industry. Bush, Andrew // Pediatric Drugs;2006, Vol. 8 Issue 5, p271 

    There is a paucity of clinical trials work in children, which leads to the frequent use of off-label and unlicensed medications in this very vulnerable group. Clinical trials work in children may be more difficult than in adults, and there are certainly ethical constraints. However, the...

  • Clinical Trials in Children. Parish, Lawrence Charles // Pediatrics for Parents;2004, Vol. 21 Issue 8, p5 

    The article focuses on clinical trials in children. Clinical trials did not always exist. When aspirin was introduced in the late nineteenth century, patients fried it but not in an organized fashion and only by chance, or perhaps it was through serendipity, that this wonder drug came to relieve...

  • Pharma Urged to Register Early Trials. Mitchell, Pete // Pharma DD: Tracking Discovery & Development;Jul/Aug2006, Vol. 1 Issue 1, p20 

    The article focuses on the proposal of the World Health Organization (WHO) concerning the publication of plans for all clinical trials by pharmaceutical companies on the Internet that include early-stage proof-of-concept studies. WHO requires all medical studies that test treatments on human...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics